Evotec valuation
Valuation
The average price target of 7 analysts is €3.75.
Data as of November 22, 2026
Evotec compared with similar companies
Evotec's Price/book: 0.69, −75% against the median of a group of 11 similar companies (2.83).
| Metric | Evotec | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 0.69 | 2.83 | 1.73 – 3.28 | Low |
| Price/sales | 0.62 | 2.17 | 1.94 – 3.80 | Low |
| Gross margin | 10.3% | 65.2% | 35.7% – 77.1% | Low |
| Operating margin | -18.0% | 16.7% | 11.3% – 23.2% | Low |
| Net margin | -25.2% | 11.9% | 7.0% – 15.5% | Low |
| ROE | -25.1% | 15.4% | 7.6% – 16.8% | Low |
| Debt/equity | 0.75 | 0.33 | 0.22 – 0.71 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Evotec: valuation over time
Evotec P/E and dividend yield at each fiscal year end, 2016 to 2025.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | €5.45 | -€0.58 | — |
| 2024 | €8.19 | -€1.11 | — |
| 2023 | €21.28 | -€0.47 | — |
| 2022 | €15.26 | -€0.99 | — |
| 2021 | €42.50 | €1.30 | 32.8 |
| 2020 | €30.28 | €0.04 | — |
| 2019 | €23.05 | €0.25 | 92.2 |
| 2018 | €17.36 | €0.56 | 31.0 |
| 2017 | €13.50 | €0.16 | 84.4 |
| 2016 | €7.44 | €0.20 | 37.2 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €445.3M
- Enterprise value
- €526.26M
- P/E (trailing 12 months)
- -2.94
- Forward P/E
- -5.49
- PEG
- 1.43
- EV/EBITDA
- -8.80
- EV/revenue
- 0.73
Profitability and growth
- ROA
- -4.9%
- ROIC
- -6.7%
- Revenue growth (year over year)
- 0.6%
- Earnings growth (year over year)
- -39.8%
Financial health
- Total cash
- €400.94M
- Total debt
- €481.81M
- Current ratio
- 2.32
- Quick ratio
- 2.00
- Altman Z-Score
- 0.21
- Piotroski F-Score
- 3.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- €3.75
- Median price target
- €3.50
- High price target
- €5.00
- Low price target
- €3.00
- Analysts with a price target
- 7
- Consensus
- Buy
- Forward EPS
- -€0.46
- EPS estimate, current year
- -€1.31
Shares and trading
- Beta
- 1.31
- Average volume
- 1.1M
- Shares outstanding
- 177.69M
- Float
- 147.01M
- Institutional ownership
- 47.7%
- Insider ownership
- 10.0%
